0
Your cart

Your cart is empty

Books > Medicine > General issues > Medical ethics

Not currently available

Countering the Problem of Falsified and Substandard Drugs (Paperback) Loot Price: R1,585
Discovery Miles 15 850
Countering the Problem of Falsified and Substandard Drugs (Paperback): Committee on Understanding the Global Public Health...

Countering the Problem of Falsified and Substandard Drugs (Paperback)

Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, Board on Global Health, Institute of Medicine; Edited by Lawrence O. Gostin, Gillian J. Buckley

 (sign in to rate)
Loot Price R1,585 Discovery Miles 15 850 | Repayment Terms: R149 pm x 12*

Bookmark and Share

Supplier out of stock. If you add this item to your wish list we will let you know when it becomes available.

The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines.

General

Imprint: National Academies Press
Country of origin: United States
Release date: June 2013
First published: 2013
Authors: Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products • Board on Global Health • Institute of Medicine
Editors: Lawrence O. Gostin • Gillian J. Buckley
Dimensions: 229 x 152 x 0mm (L x W x T)
Format: Paperback
Pages: 376
ISBN-13: 978-0-309-26939-1
Categories: Books > Medicine > General issues > Medical ethics
Books > Social sciences > Sociology, social studies > Crime & criminology > Drugs trade / drug trafficking
LSN: 0-309-26939-3
Barcode: 9780309269391

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners